| MONARCH 3: abemaciclib as initial therapy for advanced breast cancer MP Goetz, M Toi, M Campone, J Sohn, S Paluch-Shimon, J Huober, ... Journal of Clinical Oncology 35 (32), 3638-3646, 2017 | 1708 | 2017 |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ... The lancet oncology 18 (12), 1688-1700, 2017 | 701 | 2017 |
| Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with≥ 2 HER2-directed regimens: phase III NALA trial C Saura, M Oliveira, YH Feng, MS Dai, SW Chen, SA Hurvitz, SB Kim, ... Journal of Clinical Oncology 38 (27), 3138-3149, 2020 | 537 | 2020 |
| Measurements of W γ and Z γ production in pp collisions at s<? format?>=<? format?> 7 TeV<? format?> with the ATLAS detector at the LHC G Aad, T Abajyan, B Abbott, J Abdallah, S Abdel Khalek, AA Abdelalim, ... Physical Review D—Particles, Fields, Gravitation, and Cosmology 87 (11), 112003, 2013 | 354 | 2013 |
| Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial M Procter, TM Suter, E De Azambuja, U Dafni, V Van Dooren, ... Journal of Clinical Oncology 28 (21), 3422-3428, 2010 | 332 | 2010 |
| Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral … MT Abreu, V Kantorovich, EA Vasiliauskas, U Gruntmanis, R Matuk, ... Gut 53 (8), 1129-1136, 2004 | 236 | 2004 |
| Characterizing regulatory and functional differentiation between maize mesophyll and bundle sheath cells by transcriptomic analysis YM Chang, WY Liu, ACC Shih, MN Shen, CH Lu, MYJ Lu, HW Yang, ... Plant physiology 160 (1), 165-177, 2012 | 185 | 2012 |
| Preparation and properties of p-type transparent conductive Cu-doped NiO films SC Chen, TY Kuo, YC Lin, HC Lin Thin Solid Films 519 (15), 4944-4947, 2011 | 170 | 2011 |
| Preparation of NiCuZn ferrite nanoparticles from chemical co-precipitation method and the magnetic properties after sintering WC Hsu, SC Chen, PC Kuo, CT Lie, WS Tsai Materials Science and Engineering: B 111 (2-3), 142-149, 2004 | 168 | 2004 |
| Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients CC Lee, SY Chen, IJ Chang, SC Chen, SC Wu Medicine 86 (3), 138-144, 2007 | 163 | 2007 |
| Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab … N Harbeck, CS Huang, S Hurvitz, DC Yeh, Z Shao, SA Im, KH Jung, ... The Lancet Oncology 17 (3), 357-366, 2016 | 156 | 2016 |
| Distant metastasis in triple-negative breast cancer. LM Tseng, NC Hsu, SC Chen, YS Lu, CH Lin, DY Chang, H Li, YC Lin, ... Neoplasma 60 (3), 290-294, 2013 | 156 | 2013 |
| Liver fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: a prospective study of 132,377 adults SCC Chen, SP Tsai, JY Jhao, WK Jiang, CK Tsao, LY Chang Scientific reports 7 (1), 4649, 2017 | 154 | 2017 |
| Ultrasonography is superior to plain radiography in the diagnosis of pneumoperitoneum SC Chen, ZS Yen, HP Wang, FY Lin, CY Hsu, WJ Chen Journal of British Surgery 89 (3), 351-354, 2002 | 140 | 2002 |
| Technical quality of root canal treatment in Taiwan LH Chueh, SC Chen, CM Lee, YY Hsu, SF Pai, ML Kuo, CS Chen, ... International Endodontic Journal 36 (6), 416-422, 2003 | 116 | 2003 |
| LBA15 MONARCH 3: Interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+, HER2-advanced breast cancer (ABC) MP Goetz, M Toi, J Huober, J Sohn, O Tredan, IH Park, M Campone, ... Annals of oncology 33, S1384, 2022 | 111 | 2022 |
| Carbon nanodot additives realize high‐performance air‐stable p–i–n perovskite solar cells providing efficiencies of up to 20.2% HL Hsu, HT Hsiao, TY Juang, BH Jiang, SC Chen, RJ Jeng, CP Chen Advanced Energy Materials 8 (34), 1802323, 2018 | 110 | 2018 |
| An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer G Capri, J Chang, SC Chen, P Conte, K Cwiertka, G Jerusalem, Z Jiang, ... Annals of oncology 21 (3), 474-480, 2010 | 106 | 2010 |
| Subcutaneous vs intravenous trastuzumab for patients with ERBB2-positive early breast cancer: final analysis of the HannaH phase 3 randomized clinical trial C Jackisch, D Stroyakovskiy, X Pivot, JS Ahn, B Melichar, SC Chen, ... JAMA oncology 5 (5), e190339-e190339, 2019 | 92 | 2019 |
| Search for new particles decaying to ZZ using final states with leptons and jets with the ATLAS detector in sqrt (s)= 7 Tev proton-proton collisions ATLAS collaboration arXiv preprint arXiv:1203.0718, 2012 | 90 | 2012 |
